Niels Behrendt

Overview

Best Publications

• Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

  Ann L. Roldan;Maria Vittoria Cubellis;Maria Teresa Masucci;Niels Behrendt

  781
  Citations

• Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.

  M Ploug;E Rønne;N Behrendt;A L Jensen

  759
  Citations

• Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

  V Ellis;N Behrendt;K Danø

  625
  Citations

• Plasminogen activation and cancer

  Keld Danø;Niels Behrendt;Gunilla Høyer-Hansen;Morten Johnsen

  564
  Citations

• Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.

  R W Stephens;J Pöllänen;H Tapiovaara;K C Leung

  391
  Citations

• Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.

  Karin List;Christian C Haudenschild;Roman Szabo;WanJun Chen

  379
  Citations

• The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.

  N Behrendt;E Rønne;M Ploug;T Petri

  366
  Citations

• A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.

  Lars Søegaard Nielsen;G M Kellerman;N Behrendt;R Picone

  365
  Citations

• The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion

  K. Danø;N. Behrendt;N. Brunner;V. Ellis

  355
  Citations

• M2-like macrophages are responsible for collagen degradation through a mannose receptor–mediated pathway

  Daniel H. Madsen;Daniel Leonard;Andrius Masedunskas;Amanda Moyer

  349
  Citations

• The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.

  N Behrendt;M Ploug;L Patthy;G Houen

  343
  Citations

• Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.

  Vincent John Ellis;T C Wun;N Behrendt;E Rønne

  339
  Citations

• Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.

  G Høyer-Hansen;E Rønne;H Solberg;N Behrendt

  316
  Citations

• Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPAR

  T. Plesner;N. Behrendt;M. Ploug

  234
  Citations

• Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor.

  Ebbe Rønne;Niels Behrendt;Vincent Ellis;Michael Ploug

  222
  Citations

• uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion

  Lars H. Engelholm;Karin List;Karin List;Sarah Netzel-Arnett;Edna Cukierman

  194
  Citations

• The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction

  Gunilla Høyer-Hansen;Niels Behrendt;Michael Ploug;Keld Danø

  186
  Citations

• Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.

  R Picone;E L Kajtaniak;L S Nielsen;N Behrendt

  178
  Citations

• A urokinase receptor-associated protein with specific collagen binding properties.

  Niels Behrendt;Ole N. Jensen;Lars H. Engelholm;Ejvind Mørtz

  173
  Citations

• The Urokinase Receptor. Protein Structure and Role in Plasminogen Activation and Cancer Invasion

  K. Danø;N. Behrendt;B. Brunner;V. Ellis

  4
  Citations